$0.21 Earnings Per Share Expected for Cognex Co. (NASDAQ:CGNX) This Quarter

Equities analysts predict that Cognex Co. (NASDAQ:CGNX) will report $0.21 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Cognex’s earnings, with the highest EPS estimate coming in at $0.22 and the lowest estimate coming in at $0.20. Cognex posted earnings per share of $0.45 during the same quarter last year, which would suggest a negative year-over-year growth rate of 53.3%. The company is expected to announce its next quarterly earnings report on Monday, November 4th.

According to Zacks, analysts expect that Cognex will report full-year earnings of $0.86 per share for the current year, with EPS estimates ranging from $0.80 to $0.93. For the next year, analysts anticipate that the firm will report earnings of $1.09 per share, with EPS estimates ranging from $0.92 to $1.30. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that cover Cognex.

Cognex (NASDAQ:CGNX) last announced its earnings results on Monday, July 29th. The scientific and technical instruments company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. The company had revenue of $199.00 million during the quarter, compared to the consensus estimate of $194.65 million. Cognex had a return on equity of 17.81% and a net margin of 26.03%. The firm’s revenue for the quarter was down 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.31 earnings per share.

Several equities research analysts recently weighed in on the company. ValuEngine cut Cognex from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Goldman Sachs Group cut Cognex from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $45.00 to $36.00 in a research note on Tuesday, July 16th. Morgan Stanley reduced their price target on Cognex from $47.00 to $43.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 10th. BidaskClub raised Cognex from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Zacks Investment Research raised Cognex from a “sell” rating to a “hold” rating in a research note on Tuesday, July 23rd. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $50.22.

In other news, Director Dianne M. Parrotte sold 900 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $45.00, for a total value of $40,500.00. Following the sale, the director now directly owns 19,700 shares of the company’s stock, valued at $886,500. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 5.60% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in CGNX. Dimensional Fund Advisors LP boosted its position in shares of Cognex by 12.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 864,848 shares of the scientific and technical instruments company’s stock valued at $33,441,000 after buying an additional 97,348 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Cognex by 5.5% in the fourth quarter. Geode Capital Management LLC now owns 1,982,117 shares of the scientific and technical instruments company’s stock valued at $76,607,000 after acquiring an additional 102,876 shares during the period. SG Americas Securities LLC lifted its holdings in Cognex by 52.6% in the first quarter. SG Americas Securities LLC now owns 13,253 shares of the scientific and technical instruments company’s stock valued at $674,000 after acquiring an additional 4,566 shares during the period. First Republic Investment Management Inc. bought a new position in Cognex in the first quarter valued at about $275,000. Finally, Cornerstone Advisors Inc. lifted its holdings in Cognex by 123.9% in the first quarter. Cornerstone Advisors Inc. now owns 1,001 shares of the scientific and technical instruments company’s stock valued at $51,000 after acquiring an additional 554 shares during the period. 91.52% of the stock is currently owned by institutional investors.

CGNX stock traded down $0.06 during midday trading on Tuesday, hitting $49.79. The stock had a trading volume of 497,125 shares, compared to its average volume of 1,228,261. The firm has a market cap of $8.43 billion, a price-to-earnings ratio of 40.15, a price-to-earnings-growth ratio of 3.90 and a beta of 2.08. The business has a 50-day moving average of $44.98 and a two-hundred day moving average of $47.34. Cognex has a 52-week low of $34.88 and a 52-week high of $59.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.92 and a quick ratio of 7.07.

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Friday, August 16th were paid a $0.05 dividend. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.40%. Cognex’s dividend payout ratio is currently 16.13%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: How is a buy-side analyst different from a sell-side analyst?

Get a free copy of the Zacks research report on Cognex (CGNX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.